Guido Francini
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Pathology and Forensic Medicine top 1%
- Surgery top 5%
- Immunology top 5%
- Co-authors
- Daniel J. SargentDaniel G. HallerRoberto LabiancaRichard M. GoldbergJean François SeitzRoberto PetrioliLois E. ShepherdPierpaolo Correale
- Topics
- Colorectal Cancer Treatments and Studies (35 papers)Cancer Immunotherapy and Biomarkers (21 papers)Bone health and treatments (18 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Guido Francini
107 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 4.1k
- Pulmonary and Respiratory Medicine 1.3k
- Pathology and Forensic Medicine 1.1k
- Surgery 934
- Immunology 671
Countries citing papers authored by Guido Francini
This map shows the geographic impact of Guido Francini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Francini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Francini more than expected).
Fields of papers citing papers by Guido Francini
This network shows the impact of papers produced by Guido Francini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Francini. The network helps show where Guido Francini may publish in the future.
Co-authorship network of co-authors of Guido Francini
This figure shows the co-authorship network connecting the top 25 collaborators of Guido Francini. A scholar is included among the top collaborators of Guido Francini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Francini. Guido Francini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 27 | |
| 3 | 173 | |
| 4 | 49 | |
| 5 | 19 | |
| 6 | 7 | |
| 7 | 8 | |
| 8 | 42 | |
| 9 | 58 | |
| 10 | 14 | |
| 11 | 61 | |
| 12 | 72 | |
| 13 | 24 | |
| 14 | 24 | |
| 15 | 30 | |
| 16 | 21 | |
| 17 | 122 | |
| 18 | 27 | |
| 19 | 27 | |
| 20 | Radioimmunoassay for the N-terminal, C-terminal and middle region of human parathyroid hormone in bone diseases. | 4 |
About Guido Francini
Guido Francini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 113 papers that have together received 5.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Bone health and treatments (18 papers). The work is most often cited by research in Oncology (4.1k citations), Pathology and Forensic Medicine (1.1k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Guido Francini has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Daniel J. Sargent, Daniel G. Haller, Roberto Labianca, Richard M. Goldberg, Jean François Seitz, Roberto Petrioli, Lois E. Shepherd, Pierpaolo Correale, Jacqueline Benedetti and Stefania Marsili. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.